All In Biotech

Drug Trial Radar · NCT00133406

Long-term Impact and Intervention for Diarrhea in Brazil

Last checked: Nov 19, 2026Latest source record: Mar 8, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 321 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

321

Planned (sponsor's estimate)

Start

Jun 2006

Primary completion

Dec 2011

Study completion Dec 2011

Sponsor

Lead sponsor
University of VirginiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
First posted
Aug 23, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 2 months, up to 8 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives of this study are to determine the effect of 1 year supplementation of Vitamin A, Zinc, and Vitamin A plus Zinc compared to placebo on the Height for Age Z Score (HAZ) and the number of episodes of diarrhea and number of days of diarrhea at one year in children living in a Brazilian slum. Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. There is also a sub study to determine if ten days of glutamine delivered as an oral bolus improves the health of the digestive system.

Conditions

  • Diarrheal Disorder

Interventions

  • GlutamineDrug

    0.8gm/kg, ie up to a total daily dose of 16.2gm/day,with juice daily for 10 days

  • Vitamin ADrug

    100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.

  • glycineDrug

    0.4gm/kg; ie up to 8.3gm/d, with juice daily for 10 days

  • zincDrug

    40 mg twice weekly for 12 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. L:M ratio at 1.5 monthsTime frame: 1.5 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Federal University of Ceará

    Fortaleza, Brazil · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.